Intellectual Property Investment manager Robert (Rob) Fahrenheims photo of Life Sciences event and panel of people sitting on small stage addressing crowd of people. Panel made up of industry leading men and women Back to News

18th June 2019

Intellectual Property Investment Manager Robert Fahrenheim attended CDR’s ‘Life Sciences Litigation Symposium 2019’.

The enthralling daylong event saw speakers such as Celina McGregor of AstraZeneca, Will James of Osborne Clarke, Kai Gait of GSK and Nicolas Pourbaix of Amgen.

The last and insightful panel of the day, “Globalisation In Life Sciences: Is international Arbitration the future?”, was chaired by former Lord Justice of Appeal Sir Robin Jacob of 8 New Square, with speakers discussing benefits of arbitration for life sciences matters as opposed to the traditional court system. It was joined by Matt Lynde of Cornerstone Research, Laurence Lieberman of Taylor Wessing, Kathleen Denoodt and Greg Bell of Charles River Associates.

See more from Robert Fahrenheim
Biography | LinkedIn